Live
Home·Deals·M&A·Hemab Therapeutics Holdings, Inc. (COAG) IPO
SEO URLwww.firestrike.ai/deals/hemab-therapeutics-holdings-inc-coag-ipo-2026-1
ipoAnnounced · May 1, 2026
Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc.

Hemab Therapeutics Holdings, Inc. (COAG) IPO

David Najork
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
ShareXLinkedInEmail
Offering size
$243.5M
Company
Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc.
Exchange
NASDAQ Global Select
Status
expected

Hemab Therapeutics Holdings, Inc. is in the IPO process (expected). Indicative offering scale: $243.5M. Price range (when disclosed): 16.00-18.00. Sector: Not specified. Headquarters context: Location not specified. Expected listing context: NASDAQ Global Select / COAG.

This page summarizes publicly available information about the offering as of 2026-05-01. Dates, filing status, and proceeds may change as the issuer updates disclosures.

Deal timeline

Announced
May 1, 2026
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sources: FireStrike data · FireStrike proprietary index